CRISPR Therapeutics AG (CRSP): The Biotech Stock with Biggest Upside Potential
We recently published a list of the 12 Biotech Stocks with the Biggest Upside Potential. In this article, we are going to ...
CRISPR Therapeutics' SWOT analysis: gene editing pioneer's stock faces pivotal year
CRISPR Therapeutics AG (NASDAQ:CRSP), a leading biotechnology company specializing in gene-based medicines with a market capitalization of $3.45 billion, stands at a critical juncture as it navigates ...
Editas And Intellia: Strategic Shifts And Long-Term Investment Potential
A look at Intellia Therapeutics, Inc. and Editas Medicine, Inc., including their restructuring and pipeline prioritization.
Hosted on MSN7h
CRISPR Therapeutics Stock Falls 34% in a Year: Time to Buy or Sell?
Shares of CRISPR Therapeutics CRSP have lost more than 30% in the past year. Though the stock soared at the onset of 2024, ...
Camtek Stock Gets Relative Strength Rating Lift
Rating upgraded from 74 to 83 Friday. This unique rating tracks market leadership by showing how a stock's price action over ...
Hot AI Chip Stock Astera Labs Looks To Reignite Rally At A Key Support Level
AI stock Astera Labs is looking to rebound from a key support level the stock market today following a 47% advance in recent ...
Science Daily21h
Long reads successfully used to find genetic causes of rare diseases
The cause of rare diseases is increasingly being detected through genome sequencing, which involves reading the entire human DNA by first breaking it into small pieces -- short reads. Scientists found ...
Bengaluru biotech start-up opens lab to develop disease diagnostics with gene editing tech
The scientific team at the laboratory is headed by a group of women with a track record in genomic science, molecular ...